NCT00926016View on ClinicalTrials.gov

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

September 30, 2010

Conditions
Chronic Hepatitis C
Interventions
DRUG

Pioglitazone (Actos)

pioglitazone 45 mg a day

Trial Locations (1)

78234

Brooke Army Medical Center, San Antonio

All Listed Sponsors
collaborator

The Geneva Foundation

OTHER

lead

Brooke Army Medical Center

FED

NCT00926016 - Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects | Biotech Hunter | Biotech Hunter